Cargando…

A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners

BACKGROUND: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stab...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Lorraine, Carruthers, Susan, Thompson, Sandra, Cheng, Wendy, Jones, Jocelyn, Simpson, Paul, Richards, Alun, Thein, Hla-Hla, Haber, Paul, Lloyd, Andrew, Butler, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937313/
https://www.ncbi.nlm.nih.gov/pubmed/24586281
http://dx.doi.org/10.1371/journal.pone.0087564
_version_ 1782305467783970816
author Yap, Lorraine
Carruthers, Susan
Thompson, Sandra
Cheng, Wendy
Jones, Jocelyn
Simpson, Paul
Richards, Alun
Thein, Hla-Hla
Haber, Paul
Lloyd, Andrew
Butler, Tony
author_facet Yap, Lorraine
Carruthers, Susan
Thompson, Sandra
Cheng, Wendy
Jones, Jocelyn
Simpson, Paul
Richards, Alun
Thein, Hla-Hla
Haber, Paul
Lloyd, Andrew
Butler, Tony
author_sort Yap, Lorraine
collection PubMed
description BACKGROUND: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. METHOD AND FINDINGS: We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners. CONCLUSION: This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.
format Online
Article
Text
id pubmed-3937313
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39373132014-03-04 A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners Yap, Lorraine Carruthers, Susan Thompson, Sandra Cheng, Wendy Jones, Jocelyn Simpson, Paul Richards, Alun Thein, Hla-Hla Haber, Paul Lloyd, Andrew Butler, Tony PLoS One Research Article BACKGROUND: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. METHOD AND FINDINGS: We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners. CONCLUSION: This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma. Public Library of Science 2014-02-27 /pmc/articles/PMC3937313/ /pubmed/24586281 http://dx.doi.org/10.1371/journal.pone.0087564 Text en © 2014 Yap et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yap, Lorraine
Carruthers, Susan
Thompson, Sandra
Cheng, Wendy
Jones, Jocelyn
Simpson, Paul
Richards, Alun
Thein, Hla-Hla
Haber, Paul
Lloyd, Andrew
Butler, Tony
A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
title A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
title_full A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
title_fullStr A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
title_full_unstemmed A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
title_short A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
title_sort descriptive model of patient readiness, motivators, and hepatitis c treatment uptake among australian prisoners
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937313/
https://www.ncbi.nlm.nih.gov/pubmed/24586281
http://dx.doi.org/10.1371/journal.pone.0087564
work_keys_str_mv AT yaplorraine adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT carrutherssusan adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT thompsonsandra adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT chengwendy adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT jonesjocelyn adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT simpsonpaul adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT richardsalun adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT theinhlahla adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT haberpaul adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT lloydandrew adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT butlertony adescriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT yaplorraine descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT carrutherssusan descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT thompsonsandra descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT chengwendy descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT jonesjocelyn descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT simpsonpaul descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT richardsalun descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT theinhlahla descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT haberpaul descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT lloydandrew descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners
AT butlertony descriptivemodelofpatientreadinessmotivatorsandhepatitisctreatmentuptakeamongaustralianprisoners